Radioligand Therapy Shifts Paradigm in Advanced Oncology
The global Nuclear Medicine Market was valued at USD 112.73 billion in 2025 and is projected to skyrocket to USD 452.57 billion by 2034, expanding at a robust Compound Annual Growth Rate (CAGR) of 16.7% throughout the forecast period.
The global healthcare ecosystem is witnessing a definitive transition away from generalized cytotoxic treatments toward molecularly targeted precision...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek